The growing demand for wearable and Internet of Medical Things (IoMT) devices is driving the development of compact, low-power platforms for continuous physiological monitoring. Bioimpedance analysis represents a versatile non-invasive technique for the assessment of tissue properties, body composition, and respiratory dynamics. This work presents a comprehensive experimental validation of a compact bioimpedance measurement platform based on the SENSIPLUS chip, a CMOS sensor interface integrating a frequency-programmable lock-in amplifier for Electrochemical Impedance Spectroscopy in the 10 kHz–1 MHz range. The platform was validated at three complementary levels: (i) electrical characterization on Debye tissue-equivalent circuits using a three-point bilinear calibration, with analysis of the electrode–skin contribution and repeatability assessment; (ii) in vivo multi-frequency bioimpedance spectroscopy (BIS) with Cole–Cole model fitting and hook-effect correction; and (iii) single-frequency thoracic impedance plethysmography for respiratory monitoring. Results were compared against an Agilent E4980A precision Inductance (L), Capacitance (C), and Resistance (R) meter and a calibrated spirometer. The presented device achieved a maximum resistance error below 5.7% and reactance deviation under 6 Ω across the investigated frequency range, Cole–Cole parameters consistent with reference values, and strong linear correlation (𝑅2=0.97) between thoracic impedance variations and tidal volume, with respiratory rate estimation errors below 2% across the ten sessions, specifically 1.43% during normal breathing and 1.96% during deep breathing. These results demonstrate that the SENSIPLUS-based platform achieves metrological performance compatible with the requirements of wearable IoMT applications, here demonstrated in a single-subject proof-of-concept study, while relying for all critical analog functions on a compact (1.5×1.5) mm2 system-on-chip with low power consumption (1.5 mW).

Experimental Validation of a Compact and Versatile Bioimpedance Measurement Platform Based on the SENSIPLUS Chip / Giannini, L., Asquini, R., Buzzin, A., Contardi, S., Bruschi, P., Piuzzi, E.. - In: SENSORS. - ISSN 1424-8220. - 26:15(2026), pp. 1-20. [10.3390/s26154922]

Experimental Validation of a Compact and Versatile Bioimpedance Measurement Platform Based on the SENSIPLUS Chip

Lorenzo Giannini;Rita Asquini;Alessio Buzzin;Emanuele Piuzzi
2026

Abstract

The growing demand for wearable and Internet of Medical Things (IoMT) devices is driving the development of compact, low-power platforms for continuous physiological monitoring. Bioimpedance analysis represents a versatile non-invasive technique for the assessment of tissue properties, body composition, and respiratory dynamics. This work presents a comprehensive experimental validation of a compact bioimpedance measurement platform based on the SENSIPLUS chip, a CMOS sensor interface integrating a frequency-programmable lock-in amplifier for Electrochemical Impedance Spectroscopy in the 10 kHz–1 MHz range. The platform was validated at three complementary levels: (i) electrical characterization on Debye tissue-equivalent circuits using a three-point bilinear calibration, with analysis of the electrode–skin contribution and repeatability assessment; (ii) in vivo multi-frequency bioimpedance spectroscopy (BIS) with Cole–Cole model fitting and hook-effect correction; and (iii) single-frequency thoracic impedance plethysmography for respiratory monitoring. Results were compared against an Agilent E4980A precision Inductance (L), Capacitance (C), and Resistance (R) meter and a calibrated spirometer. The presented device achieved a maximum resistance error below 5.7% and reactance deviation under 6 Ω across the investigated frequency range, Cole–Cole parameters consistent with reference values, and strong linear correlation (𝑅2=0.97) between thoracic impedance variations and tidal volume, with respiratory rate estimation errors below 2% across the ten sessions, specifically 1.43% during normal breathing and 1.96% during deep breathing. These results demonstrate that the SENSIPLUS-based platform achieves metrological performance compatible with the requirements of wearable IoMT applications, here demonstrated in a single-subject proof-of-concept study, while relying for all critical analog functions on a compact (1.5×1.5) mm2 system-on-chip with low power consumption (1.5 mW).
2026
bioimpedance; wearable sensors; telemedicine; physiological monitoring; Internet of Medical Things
01 Pubblicazione su rivista::01a Articolo in rivista
Experimental Validation of a Compact and Versatile Bioimpedance Measurement Platform Based on the SENSIPLUS Chip / Giannini, L., Asquini, R., Buzzin, A., Contardi, S., Bruschi, P., Piuzzi, E.. - In: SENSORS. - ISSN 1424-8220. - 26:15(2026), pp. 1-20. [10.3390/s26154922]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1772720
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact